Speakers: 

Madelyn Zavada, Pharmacy Intern, Geisinger Wyoming Valley - has disclosed the following relationship: Employment, CVS Pharmacy. 

Emily Peleschak, Pharmacy Intern, Geisinger Wyoming Valley - has disclosed the following relationship: Employment, Rite Aid Pharmacy. 

Leah Peterman, Pharmacy Intern, Geisinger Lewistown Hospital/Geisinger Medical Center Muncy - has nothing to disclose. 

Moderator: 

Sarah F. Hale, PharmD., BCPPS; Director of Pharmacy, Geisinger Medical Center - has nothing to disclose.

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Describe the possible adverse effects of givinostat on boys with muscular dystrophy
• Evaluate the statistical and clinical results of the givinostat trial and determine if they are valuable 
• Evaluate the efficacy of an IV to PO switch in patients with uncomplicated S. aureus bacteremia.
• Develop a treatment plan for patients with uncomplicated S. aureus bacteremia. 
• Compare the efficacy of cefepime/enmetazobactam to piperacillin/​tazobactam against extended-spectrum beta-lactamase producing gram-negative bacteria. 
• Summarize cefepime/enmetazobactam’s place in therapy for the treatment of complicated urinary tract infections and pyelonephritis.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Sarah F. Hale, PharmD; Brain Simpkins, PharmD; Jessica Milheim, CPhT and Nichole Varela Gonzalez, PharmD have no identified disclosures. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant.